Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 517

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 3
Chunk 517
---
 financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and the significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe our audits provides
a reasonable basis for our opinion.

Critical
Audit Matter

The
critical audit matter communicated below is a matter arising from the current period audits of the financial statements that were communicated,
or required to be communicated, to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial
statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters
does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit
matter below, providing separate opinion on the critical audit matter or on the accounts or disclosures to which they relate.

Due
to the net loss for the year, the Company evaluated the need for a going concern.

Auditing
management’s evaluation of a going concern can be a significant judgement given the fact that the Company uses management estimates
on future revenues and expenses which are not able to be substantiated.

As
discussed in Note 2, the Company has a going concern due to its insufficient cash balance and accumulated net losses.

To
evaluate the appropriateness of the going concern, we examined and evaluated the financial information along with management’s
plans to mitigate the going concern and management’s disclosure on going concern.

/s/
M&K CPAS, PLLC

We
have served as the Company’s auditor since 2023

The
Woodlands, TX

March
11, 2025

F-2

SYRA
HEALTH CORP.

BALANCE
SHEETS

    December 31,  
    December 31, 

    2024  
    2023 

    ASSETS 

    Current assets: 

    Cash and cash equivalents 
    $2,395,405  
    $3,280,075 
  
    Accounts receivable, net 
     680,827  
     1,060,634 
  
    Accounts receivable related party 
     -  
     50,614 
  
    Accounts receivable 
     -